
Alejandro Gutierrez MD
Instructor in Pediatrics, Dana-Farber Cancer Institute
Join to view full profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-3300
Dr. Gutierrez is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2001 - 2004
Perelman School of Medicine at the University of PennsylvaniaClass of 2001
Certifications & Licensure
TN State Medical License 2024 - 2028
MA State Medical License 2004 - 2024
PA State Medical License 2001 - 2004
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Co-option of lineage plasticity as a hallmark of multipotent acute leukemias.Alejandro Gutierrez, Alex Kentsis
Blood Neoplasia. 2026-08-01 - Developmental Oncology: Principles and Therapy of Cancers of Children and Young Adults.Alex Kentsis, Alejandro Gutierrez
Cold Spring Harbor Perspectives in Medicine. 2026-07-01 - 2 citationsTargeting tRNA-Arg-TCT-4-1 suppresses cancer cell growth and tumorigenesis.Esteban A Orellana, Isobel E Bowles, Xin Yang, Anais Torres, Sally R Jamieson
Biorxiv. 2026-02-20
Press Mentions
Fascinating Adavtnages and Ease to Try Bariatric SurgeryNovember 16th, 2017
Dr. Louisiana Valenzuela, Leading Bariatric Surgeon, Chooses Mexico Bariatric Center for Her Own Weight-Loss SurgeryJanuary 13th, 2017
An Open Letter to the Senate Concerning H.R.1 and the Graduate Student Tax Provision (Signatures Continued)December 3rd, 2017
Grant Support
- Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal CancerST. JUDE CHILDREN'S RESEARCH HOSPITAL2021–2026
- Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemiasST. JUDE CHILDREN'S RESEARCH HOSPITAL2015–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









